Entrar Registro gratuito

Last updated: 21 May 2024 at 5:00pm EST

Stephen Oesterle Net Worth



Stephen Oesterle biography

Dr. Stephen N. Oesterle, M.D. serves as Independent Director of the Company. Dr. Oesterle is a consultant, advising private equity and operating companies in the healthcare industry. From 2002 to 2015, he served as a member of the Executive Committee of Medtronic (Medtronic), a global medical technology, services and solutions company, and as Medtronic’s Senior Vice President, Medicine and Technology. Previously, he served as an Associate Professor of Medicine and Director of Invasive Cardiology Services at each of Massachusetts General Hospital (1998 to 2002), Stanford University Medical Center (1992 to 1998) and Georgetown University Medical Center (1991 to 1992). He served as a director of REVA Medical, Inc. (REVA) from February 2018 to May 2019 and of HeartWare International, Inc. (HeartWare) from January 2016 to November 2016, prior to Medtronic’s acquisition of HeartWare.

What is the salary of Stephen Oesterle?

As the Independent Director of Baxter International, the total compensation of Stephen Oesterle at Baxter International is $324,757. There are 16 executives at Baxter International getting paid more, with Jose Almeida having the highest compensation of $13,913,800.



How old is Stephen Oesterle?

Stephen Oesterle is 69, he's been the Independent Director of Baxter International since 2017. There are 6 older and 23 younger executives at Baxter International. The oldest executive at Baxter International Inc. is James Gavin, 74, who is the Independent Director.

What's Stephen Oesterle's mailing address?

Stephen's mailing address filed with the SEC is C/O PARAGON 28, INC., 14445 GRASSLANDS DRIVE, ENGLEWOOD, CO, 80112.

Insiders trading at Baxter International

Over the last 22 years, insiders at Baxter International have traded over $966,809,165 worth of Baxter International stock and bought 178,227 units worth $6,261,495 . The most active insiders traders include Point Llc Loeb Daniel S Third, Michael F Mahoney, eJeffrey A Craig. On average, Baxter International executives and independent directors trade stock every 37 days with the average trade being worth of $3,609,738. The most recent stock trade was executed by Jeanne K Mason on 1 March 2024, trading 64,488 units of BAX stock currently worth $2,397,019.



What does Baxter International do?

baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile iv solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and services. the company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.



What does Baxter International's logo look like?

Baxter International Inc. logo

Baxter International executives and stock owners

Baxter International executives and other stock owners filed with the SEC include: